Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 3
2006 1
2007 3
2008 4
2009 5
2011 1
2012 7
2013 2
2014 7
2015 3
2016 6
2017 4
2018 9
2019 7
2020 9
2021 11
2022 6
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Transcription Factors and Cancer: Approaches to Targeting.
Shiah JV, Johnson DE, Grandis JR. Shiah JV, et al. Among authors: johnson de. Cancer J. 2023 Jan-Feb 01;29(1):38-46. doi: 10.1097/PPO.0000000000000639. Cancer J. 2023. PMID: 36693157 Free PMC article.
Author Correction: Head and neck squamous cell carcinoma.
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Johnson DE, et al. Nat Rev Dis Primers. 2023 Jan 19;9(1):4. doi: 10.1038/s41572-023-00418-5. Nat Rev Dis Primers. 2023. PMID: 36658129 No abstract available.
Emerging tyrosine kinase inhibitors for head and neck cancer.
Long Z, Grandis JR, Johnson DE. Long Z, et al. Among authors: johnson de. Expert Opin Emerg Drugs. 2022 Sep;27(3):333-344. doi: 10.1080/14728214.2022.2125954. Epub 2022 Sep 21. Expert Opin Emerg Drugs. 2022. PMID: 36131561 Free PMC article. Review.
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Brand TM, Hartmann S, Bhola NE, Li H, Zeng Y, O'Keefe RA, Ranall MV, Bandyopadhyay S, Soucheray M, Krogan NJ, Kemp C, Duvvuri U, LaVallee T, Johnson DE, Ozbun MA, Bauman JE, Grandis JR. Brand TM, et al. Among authors: johnson de. Cancer Res. 2022 Sep 2;82(17):3187. doi: 10.1158/0008-5472.CAN-22-1308. Cancer Res. 2022. PMID: 36052496 No abstract available.
Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Brand TM, Hartmann S, Bhola NE, Li H, Zeng Y, O'Keefe RA, Ranall MV, Bandyopadhyay S, Soucheray M, Krogan NJ, Kemp C, Duvvuri U, LaVallee T, Johnson DE, Ozbun MA, Bauman JE, Grandis JR. Brand TM, et al. Among authors: johnson de. Cancer Res. 2022 Sep 2;82(17):3188. doi: 10.1158/0008-5472.CAN-22-1307. Cancer Res. 2022. PMID: 36052495 No abstract available.
89 results